Toggle navigation
Home
Search
Services
Blog
Contact
About
Identifying Transforming Genes in Momocytic Tumors
Eccles, Michael R.
Princeton University, Princeton, NJ, United States
Search grants from Michael Eccles
Search grants from Princeton University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease
SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease
Use of Multifunctional rhPRG4 Biologic for Treatment of TBI
Glucocorticoid Receptor Regulation in Leukemia
Glutamate Stimulated Membrane Turnover in Rods
Recently added grants:
Program 10: Cancer Care Delivery Research
Program 11: Cancer Immunology
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects
Program 12: Developmental Therapeutics
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Fellowships (FIC) (F05)
Project #
1F05TW003942-01
Application #
3021308
Study Section
(BI)
Project Start
1988-06-09
Project End
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Princeton University
Department
Type
Schools of Arts and Sciences
DUNS #
002484665
City
Princeton
State
NJ
Country
United States
Zip Code
08544
Related projects
NIH 1988
F05 TW
Identifying Transforming Genes in Momocytic Tumors
Eccles, Michael R. / Princeton University
NIH 1987
F05 TW
Identifying Transforming Genes in Momocytic Tumors
Eccles, Michael R. / Princeton University
Publications
Eccles, M R; Baumbach, W R; Cole, M D
(1990)
Examination of the role of CSF-1 independence in myc retrovirus induced monocyte tumorigenesis.
Oncogene 5:1535-9
Comments
Be the first to comment on Michael Eccles's grant